The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.

The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.

Sino Biopharmaceutical announced drug development and sales pacts with two UK pharma companies on Wednesday, AstraZeneca and GSK, for separate respiratory partnerships